INTENSITY THERAPEUTICS, INC. - INTS

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$1.569M
QoQ value delta ($000)
+$859K (+120.99%)
Implied price effect (QoQ)
+66.99%
Shares
Total shares
3,919,007
QoQ shares delta
+957,574 (+32.33%)
Total shares held by funds (by quarter)

Market chart (INTS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 266 649,084 0.0%
SAPIENT CAPITAL LLC 244 650,151 0.0%
Rothschild Wealth LLC 203 495,910 0.02%
GEODE CAPITAL MANAGEMENT, LLC 188 460,248 0.0%
Mesirow Financial Investment Management, Inc. 102 251,000 0.0%
Legacy Advisors, LLC 62 153,447 0.01%
Creative Planning 58 143,136 0.0%
STATE STREET CORP 55 136,200 0.0%
BROWN ADVISORY INC 53 130,000 0.0%
Corient Private Wealth LLC 41 100,000 0.0%
Stonebridge Financial Group, LLC 31 77,377 0.0%
NORTHERN TRUST CORP 30 75,543 0.0%
Warberg Asset Management LLC 28 69,000 0.0%
JANE STREET GROUP, LLC 25 62,755 0.0%
Sigma Planning Corp 23 56,432 0.0%
Virtu Financial LLC 20 48,722 0.0%
IHT Wealth Management, LLC 20 50,483 0.0%
EWA, LLC 16 41,354 0.0%
TWO SIGMA SECURITIES, LLC 14 34,829 0.0%
One Charles Private Wealth Services, LLC 13 31,800 0.0%
BLAIR WILLIAM & CO/IL 12 30,191 0.0%
UBS Group AG 10 25,397 0.0%
NewEdge Advisors, LLC 10 25,000 0.0%
Tower Research Capital LLC (TRC) 8 21,532 0.0%
Sassicaia Capital Advisers LLC 6 15,000 0.01%